Top Picks: Accredited Activities

top-picks-wang-2022-02-17.jpg

Treatment Selection: A Focus on Prognostic Indicators

Eunice S. Wang, MD

Review of evolving treatment approaches in pediatric patients with newly diagnosed AML

Review of evolving treatment approaches in pediatric patients with newly diagnosed AML

Richard Aplenc, MD, PhD, MSCE

Mutation-Targeted AML Strategies

Mutation-Targeted AML Strategies

Amir T. Fathi, MD

Most Viewed

New Uses for Hypomethylating Agents (HMAs)

New Uses for Hypomethylating Agents (HMAs)

Brian A. Jonas, MD, PhD, FACP

What is the efficacy of high-intensity therapy and stem cell transplant in older adults compared with younger patients?

What is the efficacy of high-intensity therapy and stem cell transplant in older adults compared with younger patients?

James M. Foran, MD

A Focus on Prognostic Indicators for Treatment in Patients with AML?

A Focus on Prognostic Indicators for Treatment in Patients with AML?

Eunice S. Wang, MD
Biosimilars for Hematologic Malignancies: Dissecting Real-World Evidence and Barriers to Utilization

MediCom Oncology Links

Please visit these other members of the MediCom Oncology family of sites.

Managing MDS Managing Myeloma Managing MPN The Practical Oncologist Managing Lymphoma